What is the prevalence of Hidradenitis suppurativa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hidradenitis suppurativa affects approximately 1% of the population.

Prevalence of Hidradenitis Suppurativa

  • The prevalence of Hidradenitis suppurativa (HS) has been estimated to be around 1% in European studies 1.
  • A French population-based investigation reported a prevalence of 1% 1, while a Danish study found a prevalence of 1% (confidence intervals 0.4–2.2) 1.
  • In contrast, a US study using a health claims database estimated a lower prevalence of 0.05% 1, which may be due to selection bias and classification bias.
  • The discrepancies between European and American studies may be due to different methodologies or actual differences in prevalence/incidence of HS 1.
  • A higher prevalence of 2.1% was suggested in a study using a validated questionnaire in a population sample of 16,404 persons 1, and 4% in young adult women 1.
  • The mean incidence of HS was assessed to be 6.0 per 100,000 person-years in an American county 1.

From the Research

Prevalence of Hidradenitis Suppurativa

  • The estimated global prevalence of Hidradenitis suppurativa is found to be 0.00033-4.1% 2, 3
  • In European and US populations, the prevalence is relatively higher, ranging from 0.7-1.2% 3
  • A study in the United States reported an overall HS prevalence of 0.10%, or 98 per 100 000 persons 4
  • The prevalence of HS is highest among patients aged 30 to 39 years, with an adjusted prevalence of 172 per 100 000 4
  • HS disproportionately affects female patients, young adults, and African American and biracial patients, with adjusted prevalences of 137 per 100 000,296 per 100 000, and 218 per 100 000, respectively 4

Demographic Characteristics

  • Adults between 18 and 64 years of age comprise 92.8% of HS patients 5
  • A significant proportion of HS patients (31.5%) are enrolled in Medicare or Medicaid 5
  • HS patients are more likely to be smokers, and have associated comorbidities such as metabolic syndrome, cardiovascular disease, and mental health issues 2, 6

Epidemiology

  • The incidence of HS seems to be rising 2
  • Both genetic and environmental factors are associated with HS, including smoking, obesity, and hormonal factors 3, 6
  • HS has profound negative effects on patients' quality of life, often culminating in social withdrawal, unemployment, depression, and suicidal thoughts 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.